Safety and efficacy of intra-vitreal bevacizumab combined with supra-choroidal triamcinolone in the treatment of central retinal vein occlusion.

Phase 2

Completed

• Conditions: Central retinal vein occlusion; Macular edema; Eye - Diseases / disorders of the eye

• Registration Number: ACTRN12622000267752
• Lead Sponsor: Salahuddin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-12-30
• Study Start: 2022-02-14
• Last Update Posted: 21 February 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

1, All those patients diagnosed with central retinal vein occlusion
2, Either gender (male/female)

Exclusion Criteria

1,All those patients having poor compliance and follow up
2,All Known glaucomatous or glaucoma suspected patients
3,Eyes with opaque media in which fundus assessment was not possible like, dense cataracts, corneal opacity, vitreous bleed etc.
4,Eyes with prior lasers or injections done.
5,Eyes with complications like neo-vessels on disc and else-where in fundus and anterior segment neo-vessels.
6,Eyes with active inflammation or infection like conjunctivitis etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified